Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 201–300 of 1,006
A three-step model for the synaptic recruitment of AMPA receptors
Opazo, P., & Choquet, D. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.014 · Cited by 190
“reducing the number of surface NMDAR (Chen et al., 2002; Shankar et al., 2007; Snyder et al., 2005).”
InfluentialAlzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
von Bernhardi, R., & Eugenín, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 190
“Increasing evidence supports a link between Ab and the NMDA receptors (592).”
Zhao, W.-Q., Santini, F., Breese, R., Ross, D., Zhang, X. D., Stone, D. J., Ferrer, M., Townsend, M., Wolfe, A. L., Seager, M. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057182 · Cited by 188
Goebel-Goody, S. M., Davies, K. D., Alvestad Linger, R. M., Freund, R. K., & Browning, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.006 · Cited by 188
Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex
Yang, Y., Paspalas, C. D., Jin, L. E., Picciotto, M. R., Arnsten, A. F. T., & Wang, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307849110 · Cited by 188
“All of these disorders involve genetic alterations (24, 57–60) or molecular interactions (25, 61) of/with α7-nAChR signaling, including evidence of reduced receptor expression in PFC of patients with schizophrenia (22) or autism spectrum disorders (60).”
Synapse-Associated Protein-97 Mediates α-Secretase ADAM10 Trafficking and Promotes Its Activity
Marcello, E., Gardoni, F., Mauceri, D., Romorini, S., Jeromin, A., Epis, R., Borroni, B., Cattabeni, F., Sala, C., Padovani, A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3439-06.2007 · Cited by 187
“Recently, a close relationship between A production and NMDA receptor activity in cultured neurons has been put forward (Snyder et al., 2005).”
España, J., Giménez-Llort, L., Valero, J., Miñano, A., Rábano, A., Rodriguez-Alvarez, J., LaFerla, F. M., & Saura, C. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.015 · Cited by 187
Ferreira, I. L., Bajouco, L. M., Mota, S. I., Auberson, Y. P., Oliveira, C. R., & Rego, A. C. (2012) · Cell Calcium · doi:10.1016/j.ceca.2011.11.008 · Cited by 185
Membrane Trafficking Pathways in Alzheimer's Disease
Rajendran, L., & Annaert, W. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01332.x · Cited by 171
“This reduces glutamatergic transmission and inhibits synaptic plasticity in a process dependent on the α-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the striatalenriched protein tyrosine phosphatase STEP (127).”
Singh, S. K., Srivastav, S., Yadav, A. K., Srikrishna, S., & Perry, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7361613 · Cited by 186
Zhang, Y., Kurup, P., Xu, J., Carty, N., Fernandez, S. M., Nygaard, H. B., Pittenger, C., Greengard, P., Strittmatter, S. M., Nairn, A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013543107 · Cited by 184
“STEP61 associates with the NMDA subclass of glutamate receptors, decreases NMDA receptor (NMDAR) activity, and opposes the induction of LTP through dephosphorylation of Y(1472) on the NR2B receptor subunit, leading to endocytosis of NR1/NR2B receptors (17, 18).”
Self-citationRizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Figueiredo, C. P., Clarke, J. R., Ledo, J. H., Ribeiro, F. C., Costa, C. V., Melo, H. M., Mota-Sales, A. P., Saraiva, L. M., Klein, W. L., Sebollela, A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-13.2013 · Cited by 183
“LMW A Os reduce surface expression of GluN1 in cultured hippocampal neurons Previous studies have shown that A Os induce internalization of GluN1-containing NMDARs in cultured hippocampal neurons (Snyder et al., 2005; Lacor et al., 2007; De Felice et al., 2009; Jurgensen et al., 2011) without affecting total cellular…”
Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
Carrillo-Mora, P., Luna, R., & Colín-Barenque, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/795375 · Cited by 182
Huang, S.-M., Mouri, A., Kokubo, H., Nakajima, R., Suemoto, T., Higuchi, M., Staufenbiel, M., Noda, Y., Yamaguchi, H., Nabeshima, T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601372200 · Cited by 181
Synaptic Roles of Cdk5: Implications in Higher Cognitive Functions and Neurodegenerative Diseases
Cheung, Z. H., Fu, A. K. Y., & Ip, N. Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.024 · Cited by 182
Oliveira, T. G., Chan, R. B., Tian, H., Laredo, M., Shui, G., Staniszewski, A., Zhang, H., Wang, L., Kim, T.-W., Duff, K. E., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3317-10.2010 · Cited by 179
“For instance, A oligomers disrupt synaptic plasticity, the trafficking of glutamate receptors, dendritic spine dynamics and Ca 2 homeostasis (Demuro et al., 2005; Snyder et al., 2005; Hsieh et al., 2006; Haass and Selkoe, 2007; Shankar et al., 2007; Green and LaFerla, 2008).”
Temido-Ferreira, M., Ferreira, D. G., Batalha, V. L., Marques-Morgado, I., Coelho, J. E., Pereira, P., Gomes, R., Pinto, A., Carvalho, S., Canas, P. M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0110-9 · Cited by 179
β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure
Parodi, J., Sepúlveda, F. J., Roa, J., Opazo, C., Inestrosa, N. C., & Aguayo, L. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030023 · Cited by 179
Palop, J. J., & Mucke, L. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8097-7 · Cited by 177
“…by binding to the receptor for advanced glycation end products (Origlia et al. 2008), a7-nicotinic acetylcholine receptor (Dineley et al. 2001; Snyder et al. 2005), or prion protein (Lauren et al. 2009); impairments of astroglial or neuronal gluta- mate transporters (Harris et al. 1995;…”
Gu, Z., Liu, W., & Yan, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806508200 · Cited by 176
AMPA-silent synapses in brain development and pathology
Hanse, E., Seth, H., & Riebe, I. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3642 · Cited by 178
Toward a comprehensive neurobiology of IGF‐I
Torres‐Aleman, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20778 · Cited by 177
“The biological activity of Ab is not entirely clear, with many disparate functions being reported (Snyder et al., 2005; Li et al., 2009).”
BackgroundAβ Toxicity in Alzheimer's Disease
Cavallucci, V., D’Amelio, M., & Cecconi, F. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8251-3 · Cited by 177
“[116] demonstrated that Aβ reduces glutamatergic transmission and NMDARdependent LTP.”
Multiple Defects in Energy Metabolism in Alzheimers Disease
L. Ferreira, I., Resende, R., Ferreiro, E., C. Rego, A., & F. Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 177
“Moreover, neurons from a genetic mouse model of AD were found to express reduced amounts of surface NMDARs [136] and Aβ1-42 was also found to reduce surface expression of the NR1 subunit of NMDARs, in both cortical and hippocampal neurons [136138].”
BackgroundGlutamate-based therapeutic approaches: NR2B receptor antagonists
GOGAS, K. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.001 · Cited by 175
NMDA receptor functions in health and disease: Old actor, new dimensions
Dupuis, J. P., Nicole, O., & Groc, L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.002 · Cited by 172
Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
Paula‐Lima, A. C., Brito‐Moreira, J., & Ferreira, S. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12304 · Cited by 170
Synaptic pathology: A shared mechanism in neurological disease
Henstridge, C. M., Pickett, E., & Spires-Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 174
“One interesting potential link between amyloid-β and tau pathology is the finding that specific activation of extrasynaptic NMDA receptors enhances tau phosphorylation in cultured mouse hippocampal neurons [61].”
InfluentialHu, N.-W., Klyubin, I., Anwyl, R., & Rowan, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908083106 · Cited by 171
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice
Alves, S., Churlaud, G., Audrain, M., Michaelsen-Preusse, K., Fol, R., Souchet, B., Braudeau, J., Korte, M., Klatzmann, D., & Cartier, N. (2016) · Brain · doi:10.1093/brain/aww330 · Cited by 172
“IL-2 rescues impaired synaptic plasticity and restores decreased spine density in APP/PS1 E9 mice Amyloid-b-induced damage of synaptic transmission is one probable mechanism inducing memory impairments in APPP/S1 mice (Snyder et al., 2005).”
Alzheimer disease pathology as a host response
Castellani, R. J., Lee, H.-G., Zhu, X., Perry, G., & Smith, M. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318177eaf4 · Cited by 171
“supernatant fraction after high-speed centrifugation), nonfibrillar AA is the fundamental pathogenic event (63, 64).”
Sultana, R., Banks, W. A., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22227 · Cited by 170
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease
Rudy, C. C., Hunsberger, H. C., Weitzner, D. S., & Reed, M. N. (2015) · Aging and disease · doi:10.14336/ad.2014.0423 · Cited by 171
“The Journal of neuroscience, 26: 4690-4700 [102] Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al.”
Brouillette, J., Caillierez, R., Zommer, N., Alves-Pires, C., Benilova, I., Blum, D., De Strooper, B., & Buee, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5901-11.2012 · Cited by 170
“Previous studies have shown that synaptic loss following treatment with high concentrations or prolonged exposure of A was associated with rapid decrease in membrane expression of NMDA receptors (Snyder et al., 2005; Lacor et al., 2007; Shankar et al., 2007).”
E-I balance and human diseases – from molecules to networking
Eichler, S. A. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2008 · Cited by 167
Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities
Yu, J.-T., Chang, R. C.-C., & Tan, L. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.009 · Cited by 168
“Snyder et al. have proposed that effects of Ab on NMDA receptors may be mediated by a direct action on a7 nicotinic acetylcholine receptors (Snyder et al., 2005).”
BackgroundHu, Y., Xu, P., Pigino, G., Brady, S. T., Larson, J., & Lazarov, O. (2010) · The FASEB Journal · doi:10.1096/fj.09-136945 · Cited by 168
Arbel-Ornath, M., Hudry, E., Boivin, J. R., Hashimoto, T., Takeda, S., Kuchibhotla, K. V., Hou, S., Lattarulo, C. R., Belcher, A. M., Shakerdge, N., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0169-9 · Cited by 166
Calcium signalling and Alzheimer's disease
Berridge, M. J. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0371-4 · Cited by 167
Decker, H., Jürgensen, S., Adrover, M. F., Brito‐Moreira, J., Bomfim, T. R., Klein, W. L., Epstein, A. L., De Felice, F. G., Jerusalinsky, D., & Ferreira, S. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07058.x · Cited by 166
Bayer, T. A., & Wirths, O. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1287-x · Cited by 165
“It has been shown that Aβ is capable of regulating the amount of surface NMDA-type glutamate receptors [92].”
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Vossel, K. A., Xu, J. C., Fomenko, V., Miyamoto, T., Suberbielle, E., Knox, J. A., Ho, K., Kim, D. H., Yu, G.-Q., & Mucke, L. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201407065 · Cited by 167
“Tau may influence GSK3 through numerous pathways including PI3K–Akt (Takashima et al., 1996), protein phosphatase 1 (Kanaan et al., 2011), caspase-3–Akt (Jo et al., 2011), calcineurin (Snyder et al., 2005), and Wnt signaling (Caricasole et al., 2004).”
ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157
“PP2B regulates levels and activity of striatal-enriched protein tyrosine phosphatase (STEP) [34].”
InfluentialZhang, S., Edelmann, L., Liu, J., Crandall, J. E., & Morabito, M. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1900-07.2008 · Cited by 166
Bukke, V. N., Archana, M., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 161
Biological links between traumatic brain injury and Parkinson’s disease
Delic, V., Beck, K. D., Pang, K. C. H., & Citron, B. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00924-7 · Cited by 165
Kocsis, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.002 · Cited by 159
Hoey, S. E., Williams, R. J., & Perkinton, M. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6017-08.2009 · Cited by 178
“Furthermore, soluble A oligomers have been reported to disrupt postsynaptic glutamate receptor trafficking and signaling (Kamenetz et al., 2003; Wang et al., 2004; Roselli et al., 2005; Snyder et al., 2005; Hsieh et al., 2006; Shankar et al., 2007; Abbott et al., 2008).”
BackgroundProtein Tyrosine Phosphatases: Structure, Function, and Implication in Human Disease
Tautz, L., Critton, D. A., & Grotegut, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-562-0_13 · Cited by 157
Crimins, J. L., Pooler, A., Polydoro, M., Luebke, J. I., & Spires-Jones, T. L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.002 · Cited by 163
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
Lemoine, D., Jiang, R., Taly, A., Chataigneau, T., Specht, A., & Grutter, T. (2012) · Chemical Reviews · doi:10.1021/cr3000829 · Cited by 162
Tripathi, M. K., Kartawy, M., & Amal, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101567 · Cited by 162
Yu, S. P., Jiang, M. Q., Shim, S. S., Pourkhodadad, S., & Wei, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00636-1 · Cited by 190
Harris, S. S., Wolf, F., De Strooper, B., & Busche, M. A. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.005 · Cited by 161
“In contrast, it is more difficult to reconcile accounts of Ab-mediated reductions in glutamatergic transmission at the synaptic level (Kamenetz et al., 2003; Snyder et al., 2005) to circuit-level hyperexcitability, and this remains a topic of intense research.”
BackgroundAlzheimer's disease and post-operative cognitive dysfunction
Xie, Z., & Tanzi, R. E. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.014 · Cited by 159
Dynamic network connectivity: a new form of neuroplasticity
Arnsten, A. F. T., Paspalas, C. D., Gamo, N. J., Yang, Y., & Wang, M. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.05.003 · Cited by 160
“2A [63]).”
Dumont, M., Kipiani, K., Yu, F., Wille, E., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T., & Beal, M. F. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110209 · Cited by 160
“Synaptic alterations are increasingly connected to pathogenetic theories of AD [58-61], and synapses may be primary sites of Aβ generation or accumulation [62-65].”
Self-citationGoebel-Goody, S. M., Baum, M., Paspalas, C. D., Fernandez, S. M., Carty, N. C., Kurup, P., & Lombroso, P. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003053 · Cited by 159
“STEP regulates the phosphorylation and surface expression of both NMDARs and AMPARs (Fig.”
InfluentialSelf-citationMore than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
“Caspase-3 then activates PP2B (calcineurin), which directly dephosphorylates NMDAR at the Fyn phosphorylation site (D’Amelio et al., 2011; Kim et al., 2009; Snyder et al., 2005).”
Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
Wilcox, K. C., Lacor, P. N., Pitt, J., & Klein, W. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9691-4 · Cited by 155
“…loss, oligomers induce changes in the makeup of synaptic membranes, evident as a loss of surface glutamate receptors—both NMDA (Lacor et al. 2007; Snyder et al. 2005) and a-amino-3-hydroxyl-5methyl-4-isoxazole-propionate (AMPA; Hsieh et al. 2006) subtypes—as well as EphB2 (Lacor et al. 2007;…”
He, Y., Wei, M., Wu, Y., Qin, H., Li, W., Ma, X., Cheng, J., Ren, J., Shen, Y., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09114-z · Cited by 156
New targets for pharmacological intervention in the glutamatergic synapse
Gardoni, F., & Luca, M. D. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.022 · Cited by 171
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Yadollahikhales, G., & Rojas, J. C. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01405-0 · Cited by 154
“AβOs instigate tau pathology [15], loss of neuronal polarity [16], impairment of axonal transport [17], deterioration of synapses [18], oxidative stress [19], endoplasmic reticulum stress [20], insulin resistance [21], neuroinflammation [22], cholinergic impairment [23], loss of trophic factors [24], epigenetic change…”
BackgroundSynaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property
Sepulveda, F. J., Parodi, J., Peoples, R. W., Opazo, C., & Aguayo, L. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011820 · Cited by 154
“mechanism is available to explain this variety of effects [30–32], hindering the development of anti Ab therapies.”
Modarresi, F., Faghihi, M. A., Patel, N. S., Sahagan, B. G., Wahlestedt, C., & Lopez-Toledano, M. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/929042 · Cited by 155
“Oligomeric forms of Aβ 1–42 can induce other components of AD pathophysiology, such as mitochondrial dysfunction [2, 3], Tau hyperphosphorylation (Tau hypothesis) [4], NMDAR endocytosis (channel hypothesis), excessive calcium influx (calcium hypothesis) [5, 6], synaptic dysfunction [7], neuronal stress [8], apoptosis…”
BackgroundFerreiro, E., Baldeiras, I., Ferreira, I. L., Costa, R. O., Rego, A. C., Pereira, C. F., & Oliveira, C. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/735206 · Cited by 154
“Accordingly, neurons from a genetic mouse model of AD were found to express reduced amounts of surface GluN1 subunit [91], and Aβ1-”
BackgroundReelin signaling antagonizes β-amyloid at the synapse
Durakoglugil, M. S., Chen, Y., White, C. L., Kavalali, E. T., & Herz, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908176106 · Cited by 153
“NR2 tyrosine phosphorylation increases the expression of NMDA receptors at the cell surface by preventing their endocytosis (9).”
BackgroundInfluentialThe Toxicity of Amyloid ß Oligomers
Zhao, L. N., Long, H. W., Mu, Y., & Chew, L. Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067303 · Cited by 152
“Indeed, it is well known that Aβ oligomers can bind to several receptors [81–86] and initiate numerous signaling”
BackgroundThe PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M., & Lamb, B. T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-14 · Cited by 177
“First, this pathway acts downstream of many cell surface receptors to which Aβ has been demonstrated to interact with including the alpha 7 nicotinic acetylcholine receptor (CHRNA7), N-methyl-D-aspartic acid receptors [35,36] and insulin receptors [20].”
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory
Mansuy, I. M., & Shenolikar, S. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.10.004 · Cited by 170
Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease
Clark, B. S., & Blackshaw, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00164 · Cited by 150
“In pathological conditions, the Aβ 1–42 proteins oligomerize and contribute to the plaques that participate in AD (Abramov et al., 2004; Ohyagi et al., 2005; Snyder et al., 2005; Esposito et al., 2006; Zhu et al., 2006; Lacor et al., 2007; Matsuyama et al., 2007).”
Mitoenergetic failure in Alzheimer disease
Parihar, M. S., & Brewer, G. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2006 · Cited by 149
“A secreted into the synaptic cleft via sequential cleavage of the amyloid precursor protein (APP) promotes the endocytosis of NMDA receptors (NMDA-R), reducing their density at the synapse (245).”
BackgroundDineley, K. T., Hogan, D., Zhang, W.-R., & Taglialatela, G. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.03.010 · Cited by 149
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zlokovic, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 151
NMDA and AMPA receptors dysregulation in Alzheimer's disease
Babaei, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174310 · Cited by 161
Li, W., Yu, J., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X.-G., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0065-y · Cited by 146
Relevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A., Green, K. N., & LaFerla, F. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147
Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice
Dong, H., Martin, M. V., Chambers, S., & Csernansky, J. G. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21176 · Cited by 147
“Recent studies suggest that glutamate receptors may be involved in A -induced synaptic dysfunction (Snyder et al., 2005; Tyszkiewicz and Yan, 2005; Floden et al., 2005; Lesne et al., 2005), and soluble A -40 can induce NMDA-dependent degradation of a postsynaptic density-95 protein within…”
D’Amelio, M., & Rossini, P. M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.001 · Cited by 158
Alzheimer's disease amyloid β-protein and synaptic function
Ondrejcak, T., Klyubin, I., Hu, N.-W., Barry, A. E., Cullen, W. K., & Rowan, M. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8091-0 · Cited by 146
Phospholipase A2 and arachidonic acid in Alzheimer's disease
Sanchez-Mejia, R. O., & Mucke, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.013 · Cited by 146
Xu, J., Chatterjee, M., Baguley, T. D., Brouillette, J., Kurup, P., Ghosh, D., Kanyo, J., Zhang, Y., Seyb, K., Ononenyi, C., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001923 · Cited by 143
“of STEP in the initial synaptopathology of AD [6,16,56].”
InfluentialSelf-citationGlial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Henstridge, C. M., Tzioras, M., & Paolicelli, R. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00063 · Cited by 143
“In turn, glutamatergic signaling deficits in AD can range from NMDA and AMPAR internalization causing synaptic weakening (Zhang et al., 2003; Snyder et al., 2005) to NMDA-mediated glutamate excitotoxicity (Esposito et al., 2013).”
BackgroundPalop, J. J., Chin, J., Bien-Ly, N., Massaro, C., Yeung, B. Z., Yu, G.-Q., & Mucke, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2829-05.2005 · Cited by 144
Klein, W. L. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129039 · Cited by 141
“As reviewed below, this is the case for synapse deterioration and the related phenomenon of neuronal insulin resistance [1–6]; for neuronal tau hyperphosphorylation [7–10]; and for oxidative stress [11].”
Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment
Bell, K. F. S., Bennett, D. A., & Cuello, A. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3269-07.2007 · Cited by 142
“, 2003), thus highlighting the probability that the upregulation in terminal number is indeed functional and likely represents a compensatory response to the A -induced internalization of NMDA receptors (Snyder et al., 2005).”
InfluentialMasters, C. L., & Beyreuther, K. (2006) · Brain · doi:10.1093/brain/awl251 · Cited by 141
“…the endocytosis of the NMDA receptor [mediated in part through a-7 nicotinic receptor, protein phosphatase PP2B and tyrosine phosphatase STEP (Snyder et al., 2005)], the findings that memantine has beneficial behavioural effects in both Ab toxicity models (Yamada et al., 2005) and (i)…”
BackgroundHou, Y., Aboukhatwa, M. A., Lei, D.-L., Manaye, K., Khan, I., & Luo, Y. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.002 · Cited by 141
“Our result was consistent with previous report that NMDA receptor-activated phosphorylation of CREB is robustly reduced by Ab (Vitolo et al., 2002; Snyder et al., 2005; Matsuzaki et al., 2006).”
InfluentialRole of Aβ in Alzheimer’s-related synaptic dysfunction
Zhang, H., Jiang, X., Ma, L., Wei, W., Li, Z., Chang, S., Wen, J., Sun, J., & Li, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.964075 · Cited by 209
“One study showed that Aβ1-42 preferentially binds to glutamatergic neurons expressing NR1 or NR2B-containing NMDA receptors compared with other subunits (Lacor et al., 2007).”
BackgroundInfluentialGómez Ravetti, M., Rosso, O. A., Berretta, R., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 140
“This result supports a role for downregulation of PPP2CA, PPP3CA in AD pathology [643,644,645,646,647,648,649,650,651,652,653,654,655, 656,657,658,659,660,661,662,663,664,665,666,667,668,669,670,671].”
Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly
Ohnishi, T., Yanazawa, M., Sasahara, T., Kitamura, Y., Hiroaki, H., Fukazawa, Y., Kii, I., Nishiyama, T., Kakita, A., Takeda, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421182112 · Cited by 140
Nimmrich, V., & Ebert, U. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.1.1 · Cited by 139
Impact of social relationships on Alzheimer’s memory impairment: mechanistic studies
Hsiao, Y.-H., Chang, C.-H., & Gean, P.-W. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0404-x · Cited by 139
“Aβ-induced endocytosis of synaptic NMDA receptors [13, 14] and AMPA receptors [15], decrease in dendritic spines and disruption of the cytoskeletal network [16], activation of protein (STEP) [17–19], and disruption of neuronal glutamate uptake [20] in the affected brain regions could be the underlying mechanisms.”
Ostapchenko, V. G., Chen, M., Guzman, M. S., Xie, Y.-F., Lavine, N., Fan, J., Beraldo, F. H., Martyn, A. C., Belrose, J. C., Mori, Y., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4081-14.2015 · Cited by 138
“Of note, the action of A peptides upon NMDARs is multifaceted with either increased (Li et al., 2011; You et al., 2012) or decreased function (Snyder et al., 2005; Shankar et al., 2007) having been reported.”
InfluentialMemory Enhancement by Targeting Cdk5 Regulation of NR2B
Plattner, F., Hernández, A., Kistler, T. M., Pozo, K., Zhong, P., Yuen, E. Y., Tan, C., Hawasli, A. H., Cooke, S. F., Nishi, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.022 · Cited by 135
“Interestingly, deficiencies in NMDAR trafficking have been implicated in the pathophysiology of many of these diseases [e.g., see (Snyder et al., 2005)].”
Yamin, G. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21998 · Cited by 136
Cholesterol in Alzheimers Disease: Unresolved Questions
Stefani, M., & Liguri, G. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313899 · Cited by 133
Spines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133
“The strongest candidate for the synaptotoxic molecule around plaques arose as soluble oligomeric Aβ due to work by William Klein, Dennis Selkoe, and other groups who reported that soluble Aβ causes dendritic spine collapse and impairs synaptic plasticity in culture [40–44], correlates with memory loss in transgenic mi…”
Background
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.